We're still accepting applications for fall 2025!
Apply Today
The national vaccine strategy paid for itself after just one year, according to a study led by University of Michigan researchers. The United States prevented far more in medical spending and lost productivity than it spent on testing, buying and delivering the 2021 vaccines.
In today's challenging era for vaccines, the University of Michigan School of Public Health will host a live podcast taping April 11 in recognition of the announcement made 70 years ago at U-M, when the polio vaccine was declared safe and effective to a worldwide audience.
Epidemiologist Abram Wagner discusses why US funding for global vaccination programs benefits Americans through job creation, disease prevention, and economic stability, while building international goodwill and protecting vulnerable populations worldwide.
Five researchers at the University of Michigan School of Public Health have been awarded seed funding to prepare international research projects on a range of global health challenges, including gene therapy ethics, childhood nutrition, national food policy, cholera vaccine allocation, and occupational safety.
Vaccination against respiratory syncytial virus for adults over 60 is likely cost-effective by preventing illness, hospitalizations, lost quality of life and deaths, according to new research.
Aubree Gordon, professor of Epidemiology and Global Public Health, has been awarded a $6.7 million five-year grant to advance her innovative research into influenza immunity development among children.